Clive Ballard Selected Research

Neurobehavioral Manifestations

1/2017	Synaptic proteins in CSF relate to Parkinson's disease stage markers.
10/2011	Nonpharmacological treatment of Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Clive Ballard Research Topics

Disease

127	Dementia (Dementias) 01/2022 - 02/2002
78	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 06/2003
38	Cognitive Dysfunction 12/2022 - 11/2002
28	Parkinson Disease (Parkinson's Disease) 01/2021 - 07/2009
20	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 08/2008
15	Stroke (Strokes) 01/2022 - 01/2003
13	Pain (Aches) 01/2022 - 07/2011
12	Hallucinations (Hallucination) 01/2021 - 12/2004
8	Lewy Body Disease (Lewy Body Dementia) 01/2018 - 01/2005
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2004
4	Infections 12/2020 - 10/2015
4	Delirium 11/2020 - 10/2010
4	Disease Progression 01/2019 - 09/2014
3	Inflammation (Inflammations) 01/2022 - 09/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2019
3	Atrophy 01/2021 - 11/2007
3	Ischemic Stroke 01/2017 - 11/2013
3	Down Syndrome (Down's Syndrome) 01/2016 - 02/2012
2	Constipation 01/2022 - 01/2021
2	COVID-19 12/2021 - 12/2020
2	Synucleinopathies 01/2021 - 10/2010
2	Urinary Tract Infections (Urinary Tract Infection) 01/2021 - 01/2018
2	Amyloid Plaque 01/2021 - 07/2015
2	Venous Thromboembolism 11/2020 - 01/2020
2	Neurobehavioral Manifestations 01/2017 - 10/2011
2	Hypertension (High Blood Pressure) 01/2016 - 06/2003
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2016 - 11/2006
2	Orthostatic Hypotension (Postural Hypotension) 01/2009 - 11/2002
1	Wounds and Injuries (Trauma) 01/2022

Drug/Important Bio-Agent (IBA)

41	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 02/2002
28	Pharmaceutical PreparationsIBA 10/2021 - 01/2003
22	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
16	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2005
15	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 05/2003
15	Memantine (Namenda)FDA Link 12/2017 - 11/2006
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2010
11	pimavanserinIBA 01/2022 - 02/2014
8	Cholinergic Agents (Cholinergics)IBA 01/2020 - 06/2003
8	Antidepressive Agents (Antidepressants)IBA 09/2017 - 08/2008
7	Donepezil (Aricept)FDA LinkGeneric 01/2019 - 11/2006
6	Apolipoproteins E (ApoE)IBA 01/2019 - 04/2008
6	Analgesics (Analgesic Drugs)IBA 01/2019 - 04/2012
6	SynucleinsIBA 01/2018 - 10/2010
5	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2018 - 07/2011
5	ButyrylcholinesteraseIBA 01/2013 - 06/2003
4	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2020 - 01/2010
4	Buprenorphine (Subutex)FDA LinkGeneric 01/2018 - 07/2011
4	Rivastigmine (Exelon)FDA LinkGeneric 08/2012 - 04/2005
3	BenzodiazepinesIBA 01/2022 - 11/2020
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2012
3	Mirtazapine (Rexer)FDA LinkGeneric 10/2021 - 07/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
3	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 06/2003
3	ApolipoproteinsIBA 01/2019 - 04/2008
3	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2019 - 04/2008
3	LipidsIBA 01/2017 - 11/2013
3	LDL CholesterolIBA 01/2017 - 11/2013
3	CholesterolIBA 01/2017 - 11/2015
2	Peptides (Polypeptides)IBA 01/2022 - 01/2015
2	zopiclone (Zop)IBA 01/2021 - 11/2020
2	zaleplon (Sonata)FDA LinkGeneric 01/2021 - 11/2020
2	Zolpidem (Ambien)FDA LinkGeneric 01/2021 - 11/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2011
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2012
2	Liraglutide FDA Link 01/2020 - 01/2019
2	(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA 01/2019 - 01/2018
2	Opioid Analgesics (Opioids)IBA 01/2019 - 04/2012
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 11/2018 - 01/2018
2	ZincIBA 01/2018 - 02/2015
2	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2018 - 01/2018
2	NeurograninIBA 01/2017 - 11/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 06/2008
2	oxidized low density lipoproteinIBA 01/2017 - 11/2013
2	Quinidine (Chinidin)FDA LinkGeneric 02/2016 - 09/2015
2	Dextromethorphan (Racemethorphan)FDA LinkGeneric 02/2016 - 09/2015
2	Pemetrexed (MTA)FDA Link 03/2015 - 11/2007
2	Vitamin E FDA LinkGeneric 08/2014 - 11/2006
2	Morphine (MS Contin)FDA LinkGeneric 07/2014 - 07/2011
2	Sertraline (Zoloft)FDA LinkGeneric 02/2013 - 07/2011
2	alpha-SynucleinIBA 10/2010 - 03/2010
2	hydroxide ionIBA 01/2009 - 11/2002
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2006 - 12/2004
1	LithiumIBA 01/2022
1	SolutionsIBA 01/2022
1	Annexin A1IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022

Therapy/Procedure

22	Therapeutics 01/2022 - 06/2003
13	Home Nursing (Nursing, Home) 01/2022 - 04/2006
8	Activities of Daily Living (ADL) 12/2022 - 01/2006
5	Drug Therapy (Chemotherapy) 01/2021 - 09/2009
5	Cognitive Training 01/2020 - 10/2011
4	Institutionalization (Institutionalized Persons) 06/2020 - 07/2009
3	Aromatherapy 01/2011 - 11/2006
2	Inappropriate Prescribing 01/2022 - 01/2021
2	Pain Management 01/2018 - 07/2014
2	Transdermal Patch 07/2014 - 07/2011
2	Immunotherapy 01/2014 - 06/2012
1	Continuity of Patient Care 01/2022